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Introduction: The SARS-CoV-2 global-pandemic has caused a crisis disrupting health-systems 50 
worldwide. Whilst efforts are afoot to determine the extent of disruption, impact on gynaecological 51 
oncology trainees/training has not been explored. We conducted an international survey on impact 52 
of SARS-CoV-2 on clinical practice, medical education, and mental well-being of surgical 53 
gynaecological-oncology trainees. 54 
Methods: In our cross-sectional-survey, a customised web-based-survey was circulated to surgical 55 
gynaecological oncology trainees from national/international-organisations (May-November 2020). 56 
Validated questionnaires assessed mental well-being. Wilcoxon rank-sum test and Fisher’s exact-test 57 
tested hypothesis about differences in means and proportions. Multiple linear-regression evaluated 58 
effect of variables on psychological/mental-wellbeing outcomes. Outcomes included clinical practice, 59 
medical education, anxiety-&-depression, distress, mental well-being. 60 
Results: A total of 127 trainees from 34 countries responded. Of these, 52% (66/127) were from 61 
countries with national-training-programmes (UK/USA/Netherlands/Canada/Australia) and 48% 62 
(61/127) from no-national-training-programme countries. Altogether, 28% (35/125) had 63 
suspected/confirmed COVID19; 28% (35/125) experienced drop in household income; 20% (18/90) 64 
self-isolated from households; 45% (57/126) had to re-use personal-protective-equipment and 22% 65 
(28/126) purchased their own. In total, 32.3% (41/127) of trainees (national-training-programme-66 
trainees=16.6%(11/66); no-national-training-programme-trainees=49.1%(30/61), p=0.02) perceived 67 
they would require additional time to complete their training-fellowship. The additional training-68 
time anticipated did not differ between trainees from countries with/without national-training-69 
programmes (p=0.11) or trainees at the beginning/end of their fellowship (p=0.12). Surgical 70 
exposure was reduced for 50% of trainees. Departmental teaching continued throughout the 71 
pandemic for 69% (87/126) of trainees, albeit at reduced frequency for 16.1% (14/87), and virtually 72 
for 88.5% (77/87). Trainees reporting adequate pastoral-support (defined as allocation of a 73 
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dedicated mentor/access to occupational health support services) had better mental well-being with 74 
lower levels of anxiety/depression (p=0.02) and distress (p<0.001). National-training-programme-75 
trainees experienced higher levels of distress (p=0.01). Mean mental well-being scores were 76 
significantly higher pre-pandemic (8.3 (SD=1.6) versus post-pandemic (7 (SD=1.8);p=<0.01). 77 
Discussion: SARS-CoV-2 has negatively impacted surgical training, household income and 78 
psychological/mental well-being of surgical gynaecologic oncology trainees. Overall clinical impact 79 
was worse for no-national-training-programme versus national-training-programme-trainees, 80 
though national-training-programme-trainees reported greater distress. COVID19 sickness increased 81 
anxiety/depression. The recovery phase must focus on improving mental well-being and addressing 82 
lost training opportunities. 83 
 84 





1. COVID19 has negatively impacted training, income, mental well-being of gynaecologic 88 
oncology trainees. 89 
2. COVID19 sickness increased anxiety/depression amongst trainees. 90 
3. The recovery phase must focus on improving mental well-being and addressing lost training 91 
opportunities. 92 




On March 11, 2020 the World-Health-Organization (WHO) declared the outbreak of Coronavirus-95 
disease-2019 (COVID-19) a pandemic given its spread and severity. The cause was identified to be a 96 
novel coronavirus named severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2). SARS-97 
CoV-2 has swept the world infecting 164 million individuals and causing 3.4 million deaths worldwide 98 
(as of May 2021).1  99 
Globally an array of guidelines have been produced and implemented to restrict/modify elective-100 
surgical and oncology practice during the pandemic.2 These guidelines are intended to reduce 101 
pressure on healthcare-systems, intensive-care-units, ventilator usage, and minimise risk of 102 
nosocomial SARS-CoV-2 infection and the postoperative sequelae that may ensue. Many 103 
recommendations are pragmatic deviations from standard of care management, aiming to balance 104 
risk of treatment and available resources during this pandemic. It remains to be seen how short and 105 
long-term oncological-outcomes will be affected.3, 4 106 
Whilst data are emerging on impact of the pandemic on surgical-outcomes following cancer-surgery 107 
and its impact on healthcare-systems, there is a paucity of data on impact on trainees and no data 108 
on the impact specifically on gynaecological-oncology trainees. We present data from an 109 
international survey on impact of SARS-CoV-2 pandemic on: 1) clinical-practice, 2) medical-110 
education, and 3) mental well-being of surgical gynaecological-oncology-trainees. 111 
METHODS 112 
We sent an anonymised web-based, voluntary, open-survey to trainee surgical gynaecological-113 
oncology members of the European-Network-of-Young-Gynae-Oncologists (ENYGO), Society-of-114 
Gynecologic-Oncology (SGO), and British-Gynaecological-Cancer-Society (BGCS) between May-115 
November 2020. A survey link was circulated via social-media and email to ENYGO/BGCS/SGO 116 
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members and included in society newsletters. The survey was in English. Participants were informed 117 
of the length of time of survey, how data were stored, investigator names and study purpose.  118 
 119 
Adaptive questioning was incorporated to reduce number/complexity of questions. Respondents 120 
had the option to review/amend answers through the use of a “back” button prior to submission. IP 121 
(internet-protocol) address of the client computer was used to identify potential duplicate entries 122 
from the same user. Duplicates were excluded for data-analysis, with the first entry included. All 123 
incomplete questionnaires were included in the analysis irrespective of the number of questions 124 
completed. The eighty-one item questionnaire (Appendix-1) included a customised section covering 125 
baseline characteristics regarding the respondent’s training post, practice setting, postgraduate 126 
experience and socio-demographics. Additional questionnaire-items covered: changes in clinical and 127 
research activities/tumour board functioning/workload since pandemic onset; access to personal-128 
protective-equipment and rest-facilities whilst on shift; redeployment; COVID-19 sickness; 129 
departmental teaching; medical rotations; mental well-being. For questions pertaining to mental 130 
well-being, in addition to a customised ten-point linear scale, the validated fourteen-item Hospital-131 
Anxiety-and-Depression-Scale5 to assess anxiety and depression and fifteen-item Impact-of-Events-132 
Scale)6 to assess distress were used.  133 
Questionnaire-development 134 
An initial hard-copy draft was developed following a literature-review. Each question was 135 
systematically discussed and reviewed by gynaecological-oncology clinicians (five-trainees/five-136 
trainers from UK/US/India/Sweden) in an initial consensus meeting held face-to-face virtually. Each 137 
item was given a relevance score from 1 (least-relevant) to 4 (most-relevant) based on 138 
knowledge/experience; and identified additional questions. A second face-to-face virtual consensus 139 
meeting was held with the same ten gynaecological-oncology clinicians to review initial 140 
questionnaire responses, delete low-relevance items, optimise questionnaire length and facilitate 141 
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compliance. A pilot of the electronic-survey was undertaken for usability/technical 142 




Descriptive-statistics calculated for baseline-characteristics, clinical activities/pathways, personal-147 
protective-equipment, COVID-19 sickness, medical education. Wilcoxon rank-sum test and Fisher’s 148 
exact test were used for testing differences in means and proportions respectively. 149 
Multiple linear-regression was used to model the effect of variables on HADS, IES, mental wellbeing 150 
scales. Multiple-analyses were adjusted for gender, ethnicity, income, marital-status, religion, 151 
income, age and postgraduate experience. Two-sided p-values are reported for all statistical tests. 152 
Statistical analysis was performed using R version 3.5.1. In accordance with the journal’s guidelines, 153 
we will provide our data for the reproducibility of this study in other centres if such is requested. 154 
 155 
RESULTS 156 
A total of 127 participants from 34 countries responded. Using the human-development-index 157 
classification (a composite index of life expectancy, education, per capita income indicators, used to 158 
rank countries into four tiers of human development: very-high, high, medium, low),7 100 159 
respondents were from very-high human-development-index countries (Australia-1, Austria-2, 160 
Belgium-2, Canada-2, France-2, Germany-2, Hungary-2, Ireland-1, Italy-3, Kazakhstan-1, Netherlands-161 
2, Poland-1, Portugal-1, Romania-1, Russia-2, Singapore-4, Slovenia-2, Spain-2, Switzerland-1, 162 
Turkey-5, UK-24, USA-37); 10 from high- human-development-index countries (Azerbaijan-2, Brazil-163 
1, Colombia-1, Indonesia-1, Philippines-1, Serbia-2, Sri Lanka-1, Ukraine-1); 17 from medium-HDI 164 
countries (Guatemala-1, India-15, Nepal-1). Baseline characteristics are displayed in Table 1. In total, 165 
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52% (66/127) of respondents were from countries with national-training-programmes 166 
(UK/USA/Netherlands/Canada/Australia) and 48% (61/127) from countries without national-167 
training-programmes. National-training-programme-trainees versus no-national-training-168 
programme-trainees, were earlier on in their fellowship (p<0.01), but mean total length of 169 
fellowships (p=0.27) and mean years of postgraduate experience (p=0.14) were similar. The 170 
pandemic caused a negative impact on household income for 28% (35/125) of respondents, more so 171 
for no-national-training-programme (47.5%(28/59)) than national-training-programme (10.6%(7/66)) 172 
trainees (p<0.01). Almost a quarter (31/127) reported to be shielding (Table 1). Shielding was 173 
defined as “staying at home at all times and avoiding any face-to-face contact if you or someone in 174 
your household are clinically extremely vulnerable”. This was more common for no-national-175 
training-programme than national-training-programme trainees (p<0.01). Whilst shielding, 83.9% 176 
(26/31) of respondents were performing research activities, 35.5% (11/31) audits, 41.9% (13/31) 177 
telephone clinics, and 9.7% (3/31) no work-related activities.  178 
 179 
Overall, 28% (35/125) of trainees (national-training-programme=28.8%(19/66); no-national-training-180 
programme=27.1%(16/59)) had been off work with suspected/confirmed COVID-19. Only 82.9% 181 
(29/35) reported access to SARS-CoV-2 testing. Since the onset of the pandemic, 20% (18/90) of 182 
trainees (national-training-programme=10.4% (5/48) versus no-national-training-programme=31% 183 
(13/42), p=0.02) chose to self-isolate from their household.  184 
 185 
In total, 52% (66/127) of respondents administered chemotherapy, with 32% (21/65) reporting an 186 
increase in administration. The mean proportion increase was similar for trainees from both 187 
countries with/without national-training-programmes (20.9% (SD=11.6, range=10-50) versus 28.3% 188 
(SD=14.6, range=10-50), p=0.19). A total of 85%(108/127) of trainees stated multidisciplinary-189 
team/tumour-board meeting logistics had changed with no statistically-significant differences 190 
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between national-training-programme and no-national-training-programme-trainees (p=0.71). 191 
Overall, 80.6% (87/108) of trainees stated that meetings became virtual (instead of face-to-face), 192 
16.7% (18/108) reported shorter face-to-face meetings, and 18.5% (20/108) had less frequent 193 
meetings. When evaluating recruitment to gynaecological-oncology-studies, 74.4% (93/125) stated 194 
that this had completely-stopped/somewhat-reduced, 23.2% (29/125) reported no change, and 2.4% 195 
(3/125) reported it had somewhat-increased/increased. 196 
Table-S1 summarises access, re-use and personal purchase of personal-protective-equipment. 197 
Overall, 67% (85/126) of respondents reported adequate personal-protective-equipment “all-of-the 198 
time” and 30% (38/126) reported “some-of-the time”. In total, 45% (57/126) of respondents had to 199 
re-use and 22% (28/126) had to purchase their own personal-protective-equipment. Personal-200 
protective-equipment access was worse for no-national-training-programme trainees (p=0.003). As 201 
an example, 80% (53/66) of national-training-programme-trainees compared to 53% (32/60) of no-202 
national-training-programme trainees had personal-protective-equipment access “all-of-the-time”. 203 
Only 5% (3/60) of no-national-training-programme-trainees lacked personal-protective-equipment 204 
access “most of the time”. National-training-programme-trainees were more-likely to re-use 205 
personal-protective-equipment (53% (35/66) versus 36.7% (22/60)). More no-national-training-206 
programme-trainees needed to purchase their own personal-protective-equipment (31.7% (19/60) 207 
versus 13.6% (9/66), p=0.019). Fewer no-national-training-programme (79.7% (47/59)) versus 208 
national-training-programme-trainees (90.8% (59/65), p<0.005) had adequate on shift access to rest 209 
facilities “all/some-of-the time”.  210 
 211 
In total 13.5% (17/126) of trainees were redeployed, with majority redeployed to Obstetrics-&-212 
Gynaecology (64.7%, 11/17). National-training-programme-trainees were redeployed for shorter 213 
times (mean=35.1 (SD=30.3; range=3-80 days) than no-national-training-programme-trainees 214 
(mean=49.6 (SD=52.8; range=1-120) days, p=0.88). Overall, 88.2% (15/17) of trainees had adequate 215 
12 
 
supervision during redeployment, while 29.4% (5/17) felt/were asked to work beyond their level of 216 
clinical competence (more likely for no-national-training-programme-trainees (p=0.03, Table-S2). 217 
Overall adequate pastoral support (defined as allocation of a dedicated mentor/access to 218 
occupational health support services) during the pandemic was reported by 62/125 (49.6%) all-of-219 
the time and 40/125 (32%) some-of-the time (Table-S3). This was greater for national-training-220 
programme (87.5% (56/64)) than no-national-training-programme (75.4% (46/61)) trainees.  221 
 222 
Pre-pandemic training involved rotation to different hospitals for 56.1% (37/66) of national-training-223 
programme and 33.3% (20/60) of no-national-training-programme-trainees (p=0.01). Rotations were 224 
suspended due to SARS-CoV-2 for 36.8% (20/57) of respondents, more-likely for no-national-225 
training-programme (75% (15/20)) than national-training-programme (16.2% (6/37)) trainees 226 
(p<0.01). Departmental teaching continued throughout the pandemic for 69% (87/126) of trainees, 227 
albeit predominantly virtually for 88.5% (77/87), at reduced frequency for 16.1% (14/87), and 228 
without practical hands-on teaching for 21.8% (19/87) (Table-S4). In total, 70.1% (61/87) and 62.9% 229 
(78/124) were “very-satisfied/satisfied” with departmental-teaching during and pre-pandemic 230 
respectively (Table-S5). The majority, 88% (110/125) accessed e-learning resources during the 231 
pandemic (Table-S6). National-training-programme-trainees were more likely to access BGCS/SGO e-232 
learning and no-national-training-programme trainees preferred ESGO/IGCS (International 233 
Gynecologic Cancer Society) e-learning. The mean satisfaction with quality of e-learning provided by 234 
ESGO/IGCS/BGCS/SGO was overall high, ranging from 7.1-8.6 (1=not-at-all satisfied, 10=very 235 
satisfied) (Table-S7).  236 
 237 
Half (63/126) of the trainees reported reduced surgical exposure (“yes” respondents). Table 2 238 
summarises the mean (%) reduced exposure according to surgical modality/procedure. Greater 239 
levels of reductions were seen in no-national-training-programme versus national-training-240 
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programme-trainees. Table-S8 summarises the reasons for reduced exposure with the commonest 241 
reasons being postponement of cases (76.2%, 48/63) and referral reduction (57.1%, 36/63).  242 
 243 
Overall, 68.5% (87/127) reported a decrease in outpatient workload with the mean decrease similar 244 
for trainees from countries with/without national-training-programmes (46.6% (SD=24.3, range=12-245 
100) versus 47.5% (SD=19.8, range=10-100), p=0.59). Reasons reported for reduced outpatient 246 
workload included reduced referrals from primary-care/community-practitioners (44.9% (57/127) 247 
cases), and patients not attending scheduled outpatient-appointments (41.7% (53/127) 248 
respondents). Just 15.2% (19/125) of trainees stated their overall workload had increased and 84.8% 249 
(106/125) reported decreased overall workload. Degree of workload reduction for national-training-250 
programme-trainees (27.5% (SD=13.1% (SD=13.1; range=10-50) was lower than no-national-training-251 
programme-trainees (41.2% (SD=18.6; range=15-100), p=0.04). 252 
 253 
Overall, 32.3% (41/127) (16.6%(11/66) national-training-programme; 49.1%(30/61) no-national-254 
training-programme; p=0.02) believed they would need additional time (those who responded 255 
“definitely/probably”) to complete their training-fellowship (Table-S9). The duration of additional 256 
training time anticipated did not significantly differ between trainees from countries with/without 257 
national-training-programmes (5.1 (SD=2.8, range=3-12) versus 7.8 (SD=5.6, range=1-24) months, 258 
p=0.11) or trainees at the beginning/end of their fellowship (6.2 (SD=3.1, range=2-13) versus 6.8 (SD 259 
2.9), range=2-15), p=0.12). 260 
 261 
Mean Hospital-Anxiety-and-Depression-Scale-total (combined anxiety-and-depression scores), 262 
Hospital-Anxiety-and-Depression-Scale-anxiety, Hospital-Anxiety-and-Depression-Scale-depression, 263 
and Impact-of-Events-Scale scores were 10 (SD=6.7; range=0-29); 6.62 (SD=3.8; range=0-17); 4 264 
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(SD=3.6; range=0-13) and 18.72 (SD=16; range=0-73); respectively. Higher scores indicate greater-265 
levels of anxiety/depression/distress. Multiple-linear-regression-models explored association of 266 
covariates with HADS and IES mean-scores (Tables 3, 4 and S10). Trainees with higher household 267 
income (>$150,000 versus <$50,000) and adequate pastoral support (all/some-of-the-time versus 268 
no-most-of-the-time/not-at-all) had lower levels of anxiety&depression (p=0.02) (Table-2). However, 269 
being off work from COVID-19 sickness was associated with higher levels of anxiety&depression 270 
(p=0.02). Trainees from very-high/high versus medium HDI-countries (p=0.02) and those who 271 
received adequate pastoral-support (p<0.01) had lower levels of distress. However, distress levels 272 
were higher in national-training-programme versus no-national-training-programme-trainees 273 
(p=0.01). The mean mental wellbeing score pre-pandemic was higher (p<0.01) in comparison to 274 
post-pandemic (8.3, (SD=1.6, range=2-10) versus 7, (SD=1.8, range=2-10)). Mental well-being mean 275 
scores were not significantly associated with any covariates of interest on multiple linear regression 276 
(Table-5). 277 
DISCUSSION 278 
Summary of main results 279 
The SARS-CoV-2 pandemic has negatively impacted surgical-training and overall well-being of 280 
gynaecological-oncology-trainees. Overall, 28% of trainees had suspected/confirmed COVID-19; 28% 281 
experienced drop in household income; 24% were shielding; 20% self-isolating from their 282 
households; 13.5% redeployed; 45% re-using personal protective equipment, and 22% purchasing 283 
their own. Half reported reduction in surgical exposure and one third felt they required additional 284 
time to complete their training fellowship. This negative impact on surgical training was worse for 285 
no-national-training-programme versus national-training-programme-trainees and seen across most 286 
surgical procedures. For 69% of trainees departmental teaching continued and 88% had accessed e-287 
learning resources. Trainees with adequate pastoral-support had significantly lower anxiety-and-288 
depression (p=0.02) and lower distress levels (p<0.001). National-training-programme-trainees had 289 
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higher-levels of distress than no-national-training-programme-trainees (p=0.01). Mean mental well-290 
being scores were higher pre-pandemic versus post-pandemic (p<0.01). 291 
 292 
Results in the context of published literature 293 
Our data demonstrate a profound detrimental impact from the pandemic on surgical training, the 294 
training environment and well-being of gynaecologic oncology trainees. The fact that 50% of trainees 295 
experienced reduced surgical training and 13.5% were redeployed, supports existing data that 296 
elective surgery across hospitals was reduced/stopped to increase critical care bed capacity for 297 
patients with SARS-CoV-2 and release staff to support wider hospital responses.8-10 11 This was 298 
compounded by staff shortages and sickness, reduced theatre availability and supply chain scarcities. 299 
National/international guidelines were developed to provide a framework for continuing 300 
gynaecological cancer care and aid difficult management decisions.12, 13 This identified groups of 301 
patients where therapy may be ‘delayed’ for a period of time until the SARS-CoV-2 pandemic was 302 
controlled. Rapid guidance was produced for principles of delivering radiotherapy14 and systemic 303 
anti-cancer treatment.15 Mitigation strategies resulted in changes to surgical and systemic 304 
chemotherapy plans, treatment delays, introduction of regimens requiring less frequent treatment 305 
administration. The 37.2-80% mean reduction in surgical training opportunities for trainees observed 306 
across surgical modalities, is consistent with the overall reduction in surgical cases resulting from 307 
above strategies and findings from a global modelling analysis suggesting 38% cancer and 82% 308 
benign surgeries may be postponed during the pandemic.16 This is also in keeping with data from 309 
other surgical specialities where trainees reported a reduction (50-90%) in surgical-training 310 
opportunities.17-19 These effects are corroborated by our data which report increased chemotherapy 311 
administration, postponement of surgical cases, reduced referrals, treatment pathway modification 312 




National-training-programme-trainees were less likely to believe they would need additional time to 315 
complete their training-fellowship versus no-national-training-programme-trainees (p=0.02). This 316 
may be because they were earlier in their fellowship (mean 1.6 versus 2.3 years). It also reflects 317 
benefits of structured accredited training programmes in gynaecologic oncology which are 318 
associated with better educational climates along with better quality/higher training satisfaction.10, 319 
20, 21 Such programmes are more likely to adapt and implement changes to ensure timely progression 320 
and completion of training. It is encouraging that despite the increased pressure on global 321 
healthcare systems, delivery of departmental teaching continued for 69% and consistent with the 322 
move towards remote/virtual working practices, was predominantly delivered via virtual platforms 323 
in 89% cases. However, there was no practical hands-on teaching for 21.8% of trainees. Simulation 324 
training has long been used in general surgery as a supplement to clinical surgical training as part of 325 
a balanced curriculum and has been shown to flatten the learning curve of complex surgical 326 
procedures and enhance patient safety.22-25 It is a teaching method often underutilised in 327 
gynaecologic oncology that warrants greater attention to enable the continued development of 328 
surgical skills in times of reduced exposure. The majority of trainees, 88% had accessed e-learning 329 
resources during the pandemic with high levels of satisfaction (mean satisfaction 7.1-8.6). Access to 330 
ESGO/IGCS e-learning was lower amongst national-training-programme-trainees (predominantly 331 
UK/USA trainees) potentially because a larger proportion were accessing national teaching resources 332 
produced by national organisations (BGCS–UK/SGO-USA).  333 
 334 
Three in ten trainees had COVID19 and this was associated with increased anxiety&depression. 335 
These results are in keeping with published literature confirming a negative impact on the mental 336 
well-being of general obstetrics and gynaecology trainees.26 Trainees with adequate pastoral-337 
support had lower-levels of anxiety-and-depression and distress. This is in keeping with published 338 
data supporting the positive impact of pastoral support on the mental well-being of medical 339 
17 
 
practitioners.27, 28 The reasons for higher levels of distress observed in national-training-programme-340 
trainees versus no- national-training-programme-trainees are likely multifactorial and warrant 341 
further research. Potential reasons may include greater need to re-use personal protective 342 
equipment (53% versus 36.7%); and needing to cope with greater levels of gynaecologic oncology 343 
workloads (p=0.04). Additionally, 92.4% of national-training-programme-trainees were from the 344 
UK/USA, and the considerably higher mortality rates seen in the UK/USA populations may have 345 
detrimentally affected mental well-being. Data have suggested that country specific mortality rates 346 
have been detrimentally impacted by high levels of national obesity, low levels of national 347 
preparedness, insufficient scale of testing/track-and-trace facilities, delayed national lockdowns and 348 
delays in border closures.29, 30 Data also indicate that prolonged and recurrent lockdowns have 349 
adversely affected mental well-being.31 The limitations of access to personal protective equipment 350 
are unfortunate and consistent with media and literature reports.10 Trainees have had to cope with 351 
other stresses like reduction in household income (potentially explained by increased expenditure 352 
from purchasing personal protective equipment, additional childcare costs secondary to school 353 
closures, additional accommodation costs incurred due to self-isolation; or income reduction due to 354 
shielding, COVID19 related sickness, and job loss amongst non-medical partners. It is possible that 355 
deterioration of mental well-being was confounded by aforementioned factors external to the work 356 
environment and in keeping with general population data.31, 32  357 
Strengths-and-weaknesses 358 
Strengths include that this is the first study internationally reporting impact of SARS-CoV-2 on 359 
surgical gynaecologic oncology-trainees. Validated questionnaires were used to evaluate 360 
psychological/mental well-being and changes in pre-and post-pandemic mental well-being were 361 
quantified through comparison of a customised mental well-being scale. Risk of recall bias was 362 
minimised by circulating the survey during the first pandemic wave. Limitations include that because 363 
the survey was circulated during the first SARS-CoV-2 wave and a large proportion of countries have 364 
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subsequently experienced multiple waves with sustained pressure on healthcare systems, the 365 
responses demonstrate short-term impact and long-term impact has not been evaluated. Results 366 
may not be completely generalizable to trainees globally as a number of countries are not well 367 
represented, the survey was available in English only excluding non-English speakers, there may 368 
have been an element of selection bias due to the use of social media platforms to circulate the 369 
survey link and because the majority of respondents were members of BGCS/SGO/ENYGO and likely 370 
to be motivated by career development. Responses received for subjective questionnaire items may 371 
have been influenced by the current mental state of respondents. 372 
 373 
Implications for practice and future research 374 
It must be the responsibility of employers in tandem with government agencies to ensure adequate 375 
supply of personal protective equipment and put in place provisions to ensure income protection. 376 
This may include the provision of free staff accommodation for individuals requiring to self-isolate or 377 
subsidised childcare costs. Training programme directors and societies have a responsibility to 378 
ensure continuation of development of surgical skills through the provision of virtual learning 379 
(webinars/surgical-videos) and simulation training. Study budgets could be used to purchase 380 
simulation equipment with simulation training included in national/international curriculums as a 381 
method for achieving surgical competencies. Pastoral support should be governed by codes of 382 
conduct with training programme directors, educational offices responsible for producing clear 383 
guidelines on how this may be accessed. The onus must be on trainees to access this support when 384 
needed. A future cohort study evaluating the long-term impact of the SARS-CoV-2 pandemic on 385 





Data show the SARS-CoV-2 pandemic has negatively impacted surgical training and mental well-389 
being of surgical gynaecologic oncology trainees. Recognising medical practitioners are exposed to 390 
additional unique work-related stressors as well as shared common stressors experienced by the 391 
general population secondary to the pandemic is vital. In addition to lost training opportunities, 392 
focusing on improving the mental well-being of trainees is vital for the recovery phase. 393 
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Table 1. Baseline characteristics of cohort 514 
 515 
 








Human development Index (HDI) 
   
Very high 66/66, 100 34/61, 55.7 <0.001 
High 0 10/61, 16.3 
Medium 0 17/61, 27.9 
Mean current year of fellowship (SD, range) 1.6 (0.7, 1-4) 2.3 (1.3, 1-8) <0.001 
Mean total years of fellowship (SD, range) 2.8 (0.7, 1-4) 2.9 (1.3, 1-8) 0.274 
Mean years of postgraduate experience (SD, range) 7.2 (4.3, 1-16) 6 (3.6, 0-13) 0.140 
Healthcare sector of work* 
   
Government/state funded 61/66, 92.4 55/61, 90.2 0.360 
Private 15/66, 22.7 8/61, 13.1 
Both (government and private) 10/66, 15.2 2/61, 3.3 
Mean age (SD, range) 34.5, (3.4, 30-42) 34 (4.2, 23-45) 0.622 
Gender 
   
Male respondents 21/66, 31.8 24/59, 40.7 0.353 
Female respondents 45/66, 68.2 35/59, 59.3 
Ethnicity 
   
White 49/66, 74.2 34/59, 57.6 0.070 
Asian 10/66, 15.2 20/59, 33.9 
Black 1/66, 1.5 2/59, 3.4 
Mixed 5/66, 7.6 3/59, 5.1 
Other 1/66, 1.5 0/59, 0 
Religion 
   
Muslim 2/65, 3.1 10/59, 16.9 <0.001 
Christian 23/65, 35.4 23/59, 39 
Jewish 6/65, 9.2 0/59, 0 
Hindu 3/65, 4.6 15/59, 25.4 
Buddhist 0/65, 0 1/59, 1.7 
None 31/65, 47.7 10/59, 16.9 
Marital status 
   
Married 47/66, 71.2 33/59, 55.9 0.090 
Cohabiting/living with partner 9/66, 13.6 9/59, 15.3 
Single 10/66, 15.2 13/59, 22 
Divorced/separated 0/66, 0 4/59, 6.8 
Household income in last 12 months (USD) 
   
<$50,000 0/65, 0 35/58, 60.3 <0.001 
$50,000-$100,000 24/65, 36.9 16/58, 27.6 
$100,000-$150,000 19/65, 29.2 3/58, 5.2 
>$150,000 22/65, 33.8 4/58, 6.9 
Shielding** 
   
Yes 7/66, 10.6 25/61, 41 <0.001 
No 59/66, 89.4 36/61, 59 
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Denominator for each demographic questionnaire item represents total number of respondents for 516 
that particular question. Incomplete questionnaires were included in the analysis resulting in varying 517 
denominators per item. 518 
 519 
*Respondents working at “both” are also counted in the individual categories of “government” and 520 
“private”. 521 
 522 
**Shielding defined as staying at home at all times and avoiding any face-to-face contact if you or 523 
someone in your household are clinically extremely vulnerable. 524 
  525 
25 
 
Table 2. Mean reduction in surgical exposure for trainees according to surgical modality and 526 




National training programme P value 
 Yes No 
Surgical modality/procedure Mean (SD, range) Mean (SD, range) 
Robotic  46.7 (41, 0-100) 80 (30.9, 0-100) 0.041 
Laparoscopic  47.2 (38.4, 0-100) 66.5 (26.1, 0-100) 0.058 
Open surgical procedures  37.2 (27.5, 0-100) 48.9 (20, 0-100) 0.027 
Ovarian cancer cytoreductive surgery 44 (29.4, 0-100) 45.5 (29.4, 0-100) 0.799 
Exenteration procedures 34.4 (41.6, 0-100) 61.7 (41.4, 0-100) 0.036 
Surgery for recurrent disease 54.2 (39.5, 0-100) 52.1 (30.2, 0-100) 0.814 
Radical vulval surgery 26.3 (35, 0-100) 47.6 (32.6, 0-100) 0.016 
Radical hysterectomy 20.8 (33.8, 0-100) 42.1 (31, 0-100) 0.007 
Pelvic lymphadenectomy 28.4 (36.8, 0-100) 40.7 (29.6, 0-100) 0.078 
Para-aortic lymphadenectomy 35.3 (40.9, 0-100) 46.6 (29.5, 0-100) 0.121 
Trachelectomy 15 (31.2, 0-100) 58.3 (37.9, 0-100) 0.001 
 530 
  531 
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Table 3. Factors affecting HADS total mean scores 532 
HADS – Hospital Anxiety and Depression Scale questionnaire; HDI – Human Development Index; PPE 533 
– Personal Protective Equipment. 534 
 535 
Model and variable Coef. Std. Err P>|z| 95% CI 
HADS model (total), n=90     
Gender  -2.024 1.401 0.154 -4.828  to  0.781 
Ethnicity  1.545 1.775 0.388 -2.007  to  5.098 
Income  -6.765 2.768 0.018 -12.306  to  -1.225 
Marital status  -0.641 2.146 0.766 -4.936  to  3.654 
Religion  -1.737 1.525 0.259 -4.79  to  1.316 
Age -0.451 0.27 0.101 -0.992  to  0.09 
Healthcare sector (both vs private) 2.081 3.533 0.558 -4.99  to  9.153 
Healthcare sector (government vs private) 1.348 2.9 0.644 -4.456  to  7.153 
Postgraduate experience -0.075 0.231 0.748 -0.538  to  0.389 
Total years of fellowship -1.193 0.704 0.096 -2.603  to  0.216 
HDI  -0.798 3.183 0.803 -7.169  to  5.573 
National training programme  1.374 1.863 0.464 -2.355  to  5.103 
Shielding  -1.193 1.951 0.543 -5.098  to  2.713 
Additional training time  1.879 1.819 0.306 -1.763  to  5.52 
Overall increase in clinical workload  0.631 2.386 0.793 -4.145  to  5.406 
PPE access  -6.52 4.36 0.14 -15.247  to  2.206 
COVID-19 sickness 3.754 1.493 0.015 0.766  to  6.742 
Redeployment  1.064 2.17 0.626 -3.279  to  5.408 
Adequate pastoral support  -5.543 1.752 0.002 -9.051  to  -2.036 
 536 
Multiple linear regression models evaluating the association of covariates with HADS mean scores. 537 
Models adjusted for gender, ethnicity, income, marital status, religion, income, age and 538 
postgraduate experience.  539 
 540 
HADS is a 14 item validated questionnaire with 7 items pertaining to anxiety and 7 to depression. 541 
Each item scored on a four point Likert-scale from 0-3 and total scores ranging from 0-42. Higher 542 
scores indicate greater levels of anxiety/depression. 543 
 544 
Gender: male versus female 545 
Ethnicity: white (reference category) versus non-white 546 
Income: >$150,000 (reference category) versus <$50,000 547 
Marital status: married/cohabiting (reference category) versus single/divorced 548 
Religion: Muslim/Christian/Jewish/Hindu/Buddhist (reference category) versus none 549 
27 
 
Age: age in years (continuous variable) 550 
Healthcare sector: trainees working in both government and private healthcare settings versus 551 
private only (reference category) 552 
Healthcare sector: trainees working in government only healthcare settings versus private only 553 
(reference category) 554 
Postgraduate experience: number of years (continuous variable) 555 
Total years of fellowship: number of years (continuous variable) 556 
HDI: very high/high (reference category) versus medium 557 
National training programme: yes (reference category) versus no 558 
Shielding: yes (reference category) versus no 559 
Additional training time: definitely/probably/don't know (reference category) versus probably 560 
not/definitely not 561 
Overall increase in clinical workload: yes (reference category) versus no 562 
PPE access: yes all the time/yes some of the time (reference category) versus no most of the 563 
time/not at all 564 
COVID-19 sickness: yes (reference category) versus no 565 
Redeployment: yes (reference category) versus no 566 
Adequate pastoral support: yes all the time/yes some of the time (reference category) versus no 567 
most of the time/not at all 568 
  569 
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Table 4. Factors affecting IES mean scores 570 
IES – Impact of Event Scale questionnaire; HDI – Human Development Index; PPE – Personal 571 
Protective Equipment. 572 
 573 
Model and variable Coef. Std. Err P>|z| 95% CI 
IES model, n=118     
Gender -4.765 2.951 0.11 -10.636  to  1.106 
Ethnicity  -1.743 3.776 0.646 -9.256  to  5.77 
Income  -8.123 5.964 0.177 -19.989  to  3.743 
Marital status  -5.201 4.042 0.202 -13.244  to  2.842 
Religion  -4.414 3.249 0.178 -10.879  to  2.051 
Age -0.117 0.501 0.815 -1.113  to  0.879 
Healthcare sector (both vs private) 0.741 6.986 0.916 -13.159  to  14.64 
Healthcare sector (government vs private) 1.727 5.454 0.752 -9.125  to  12.578 
Postgraduate experience -0.099 0.445 0.825 -0.984  to  0.786 
Total years of fellowship -1.358 1.669 0.418 -4.678  to  1.962 
HDI  -14.951 6.177 0.018 -27.241  to  -2.66 
National training programme  10.344 4.007 0.012 2.371  to  18.316 
Shielding  0.719 4.015 0.858 -7.269  to  8.708 
Additional training time  5.712 3.641 0.121 -1.534  to  12.957 
Overall increase in clinical workload  -1.614 4.664 0.73 -10.894  to  7.666 
PPE access  -18.193 10.273 0.08 -38.633  to  2.246 
COVID19 sickness  1.163 3.106 0.709 -5.017  to  7.342 
Redeployment  -3.614 4.651 0.439 -12.868  to  5.641 
Adequate pastoral support  -14.718 4.016 <0.001 -22.71  to  -6.727 
 574 
Multiple linear regression model evaluating the association of covariates with IES mean scores. 575 
Model adjusted for gender, ethnicity, income, marital status, religion, income, age and postgraduate 576 
experience.  577 
 578 
IES is a 15 item validated questionnaire. Each item scored on a four point Likert-scale from 0-5 with 579 
total scores ranging from 0-75. Higher scores indicate higher distress levels. 580 
 581 
Gender: male versus female 582 
Ethnicity: white (reference category) versus non-white 583 
Income: >$150,000 (reference category) versus <$50,000 584 
Marital status: married/cohabiting (reference category) versus single/divorced 585 
Religion: Muslim/Christian/Jewish/Hindu/Buddhist (reference category) versus none 586 
Age: age in years (continuous variable) 587 
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Healthcare sector: trainees working in both government and private healthcare settings versus 588 
private only (reference category) 589 
Healthcare sector: trainees working in government only healthcare settings versus private only 590 
(reference category) 591 
Postgraduate experience: number of years (continuous variable) 592 
Total years of fellowship: number of years (continuous variable) 593 
HDI: very high/high (reference category) versus medium 594 
National training programme: yes (reference category) versus no 595 
Shielding: yes (reference category) versus no 596 
Additional training time: definitely/probably/don't know (reference category) versus probably 597 
not/definitely not 598 
Overall increase in clinical workload: yes (reference category) versus no 599 
PPE access: yes all the time/yes some of the time (reference category) versus no most of the 600 
time/not at all 601 
COVID-19 sickness: yes (reference category) versus no 602 
Redeployment: yes (reference category) versus no 603 
Adequate pastoral support: yes all the time/yes some of the time (reference category) versus no 604 
most of the time/not at all 605 
  606 
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Table 5. Factors affecting mental wellbeing mean scores since the onset of the SARS-CoV-2 607 
pandemic 608 
HDI – Human Development Index; PPE – Personal Protective Equipment. 609 
 610 
Model and variable Coef. Std. Err P>|z| 95% CI 
Mental wellbeing, n=126     
Gender 0.069 0.374 0.855 -0.674  to  0.811 
Ethnicity -0.002 0.485 0.997 -0.966  to  0.962 
Income 1.034 0.741 0.167 -0.439  to  2.507 
Marital status 0.292 0.511 0.569 -0.724  to  1.309 
Religion  0.104 0.426 0.808 -0.743  to  0.95 
Age 0.096 0.061 0.118 -0.025  to  0.218 
Healthcare sector (both vs private) -0.451 0.896 0.616 -2.231  to  1.329 
Healthcare sector (government vs private) -0.23 0.689 0.739 -1.599  to  1.138 
Postgraduate experience -0.006 0.057 0.923 -0.119  to  0.108 
Total years of fellowship 0.097 0.194 0.62 -0.289  to  0.483 
HDI  0.281 0.75 0.709 -1.209  to  1.771 
National training programme  -0.689 0.519 0.188 -1.72  to  0.343 
Shielding  0.201 0.5 0.688 -0.792  to  1.195 
Additional training time  -0.8 0.465 0.089 -1.724  to  0.124 
Overall increase in clinical workload  -0.224 0.598 0.708 -1.413  to  0.964 
PPE access -0.766 1.14 0.504 -3.032  to  1.501 
COVID19 sickness  -0.011 0.396 0.977 -0.798  to  0.776 
Redeployment  -0.59 0.545 0.282 -1.674  to  0.494 
Adequate pastoral support  0.717 0.501 0.156 -0.279  to  1.714 
 611 
A multiple linear regression model exploring the association of covariates with mental wellbeing 612 
mean scores since the onset of the pandemic. Model adjusted for gender, ethnicity, income, marital 613 
status, religion, income, age and postgraduate experience.  614 
 615 
Linear customised scale where 1=extremely poor mental wellbeing, 10=excellent mental wellbeing. 616 
 617 
Gender: male versus female 618 
Ethnicity: white (reference category) versus non-white 619 
Income: >$150,000 (reference category) versus <$50,000 620 
Marital status: married/cohabiting (reference category) versus single/divorced 621 
Religion: Muslim/Christian/Jewish/Hindu/Buddhist (reference category) versus none 622 
Age: age in years (continuous variable) 623 
Healthcare sector: trainees working in both government and private healthcare settings versus 624 
private only (reference category) 625 
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Healthcare sector: trainees working in government only healthcare settings versus private only 626 
(reference category) 627 
Postgraduate experience: number of years (continuous variable) 628 
Total years of fellowship: number of years (continuous variable) 629 
HDI: very high/high (reference category) versus medium 630 
National training programme: yes (reference category) versus no 631 
Shielding: yes (reference category) versus no 632 
Additional training time: definitely/probably/don't know (reference category) versus probably 633 
not/definitely not 634 
Overall increase in clinical workload: yes (reference category) versus no 635 
PPE access: yes all the time/yes some of the time (reference category) versus no most of the 636 
time/not at all 637 
COVID-19 sickness: yes (reference category) versus no 638 
Redeployment: yes (reference category) versus no 639 
Adequate pastoral support: yes all the time/yes some of the time (reference category) versus no 640 
most of the time/not at all 641 
 642 
 643 
